Gilead Sciences
GILD
#125
Rank
โ‚น13.670 T
Marketcap
โ‚น11,018
Share price
-1.90%
Change (1 day)
45.23%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): โ‚น858.50 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are โ‚น29.08 Billion. In 2024 the company made an earning of โ‚น61.99 Billion a decrease over its 2023 earnings that were of โ‚น616.30 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น858.50 B1284.72%
2024 โ‚น61.99 B-89.94%
2023 โ‚น616.30 B17.97%
2022 โ‚น522.40 B-29.77%
2021 โ‚น743.80 B395.99%
2020 โ‚น149.96 B-67.66%
2019 โ‚น463.64 B-33.84%
2018 โ‚น700.76 B-42.35%
2017 โ‚น1.215 T-20.87%
2016 โ‚น1.536 T-21.06%
2015 โ‚น1.946 T45.8%
2014 โ‚น1.334 T253.01%
2013 โ‚น378.12 B16.51%
2012 โ‚น324.54 B-1.07%
2011 โ‚น328.05 B-6.71%
2010 โ‚น351.64 B11.75%
2009 โ‚น314.66 B29.5%
2008 โ‚น242.98 B19.11%
2007 โ‚น203.99 B-455.74%
2006 -โ‚น57.35 Billion-154.93%
2005 โ‚น104.39 B76.99%
2004 โ‚น58.98 B-266.16%
2003 -โ‚น35.5 Billion-638.24%
2002 โ‚น6.59 B31.5%
2001 โ‚น5.01 B-242.15%
2000 -โ‚น3.53 Billion-40.2%
1999 -โ‚น5.9 Billion31.85%
1998 -โ‚น4.48 Billion8.73%
1997 -โ‚น4.12 Billion27.22%
1996 -โ‚น3.24 Billion
1994 -โ‚น3.09 Billion26.57%
1993 -โ‚น2.44 Billion46.49%
1992 -โ‚น1.67 Billion362.5%
1991 -โ‚น0.36 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚น740.74 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น400.87 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น149.15 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น89.40 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น171.08 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.064 T 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.910 T 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.022 T 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.074 T 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA